Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: A randomized, double-blind, placebo-controlled trial

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 1221-1226

  Drenth, Joost P H ^a   Vonk, Alieke G ^a   Simon, Anna ^a   Powell, Richard ^b   Van Der Meer, Jos W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN D; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEOPTERIN; PLACEBO; PROTEIN P55; PROTEIN P75; SERUM AMYLOID A; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FEVER; HUMAN; HYPERIMMUNOGLOBULINEMIA; MALE; PERIODIC FEVER SYNDROME; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; URINALYSIS;

ACUTE-PHASE REACTION; ADULT; CROSS-OVER STUDIES; CYTOKINES; DNA MUTATIONAL ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; FEVER; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOGLOBULIN D; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEOPTERIN; RECURRENCE; SYNDROME; THALIDOMIDE; TREATMENT OUTCOME;

EID: 0034888835     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers
2. Familial Mediterranean fever
3. Thalidomide: Current and potential clinical applications
4. Molecular Analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome
5. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome
6. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells
7. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients
8. Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinemia D and periodic fever syndrome
9. Periodic fevers enter the era of molecular diagnosis
10. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome
11. Endurance run increases circulating IL-6 and IL-1ra but down-regulates ex vivo TNF-alpha and IL-1 beta production
12. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial
13. Monoclonal antibody-based ELISA for human SAA
14. Neopterin levels and pulmonary tuberculosis in infants
15. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinemia D and periodic fever syndrome
16. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection
17. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: Comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products
18. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: Comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products
19. Urine neopterin: A new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus
20. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation
21. Hyper-IGD syndrome: A new case treated with colchicine
22. New roles for thalidomide
23. Thalidomide. Current uses
24. Behcet's disease
25. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
26. High urinary neopterin levels in Familial Mediterranean Fever
27. Hyperimmunoglobulinemia D and periodic fever: A new syndrome
28. Immunomodulation by thalidomide: Systematic review of the literature and of unpublished observations